U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q 

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended:SeptemberJune 30, 20192020

OR

 

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________

 

Commission file number:000-55269

 

MOJO Organics, Inc.
(Exact name of registrant as specified in its charter)

 

Delaware 26-0884348
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)  

 

185 Hudson Street, Floor 25  
Jersey City, New Jersey 07302

(Address of principal executive

offices)

 (Postal Code)

 

Registrant’s telephone number:929 264 7944

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes   No 

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

Yes   No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a smaller reporting company. See the definitions of the “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

Large Accelerated FilerAccelerated Filer
Non-Accelerated FilerSmaller reporting company
(Do not check if a smaller reporting company) 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  

Yes   No 

 

On SeptemberJune 30, 2019,2020, there were 28,910,35629,924,544 shares of the registrant's common stock, par value $0.001, issued and outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

None. 

 i1 

 

 

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION Page
ITEM 1. FINANCIAL STATEMENTS (Unaudited) 
Condensed Balance Sheets as of SeptemberJune 30, 20192020 and December 31, 201820191
Condensed Statements of Operations for the ninesix months ended SeptemberJune 30, 20192020 and SeptemberJune 30, 201820192
Condensed Statements of Operations for the three months ended SeptemberJune 30, 20192020 and SeptemberJune 30, 201820193
Condensed Statements of Cash Flows for the ninesix months ended SeptemberJune 30,2020 and June 30, 2019 and September 30, 20184
Condensed Statement of Changes in Stockholders’ Equity for the ninesix months ended SeptemberJune 30, 201920205
Notes to the Condensed Financial Statements6
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS1512
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK1815
ITEM 4. CONTROLS AND PROCEDURES1815
PART II – OTHER INFORMATION 
ITEM 1. LEGAL PROCEEDINGS1916
ITEM 1a. RISK FACTORS1916
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS1916
ITEM 3. DEFAULTS UPON SENIOR SECURITIES1916
ITEM 4. MINE SAFETY DISCLOSURE1916
ITEM 5. OTHER INFORMATION1916
ITEM 6. EXHIBITS2017
SIGNATURESSIGNATURE22

 

PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS (Unaudited)

MOJO ORGANICS, INC.
Condensed Balance Sheets (Unaudited)
As of June 30, 2020 and December 31, 2019
     
  June 30,
2020
 December 31, 2019
ASSETS  
CURRENT ASSETS:        
Cash and cash equivalents $14,878  $55,978 
Accounts receivable, net  96,627   75,087 
Inventory  213,142   175,719 
Supplier deposits  39,000   11,539 
Prepaid expenses  18,487   14,767 
Security deposit  4,518   4,518 
Total Current Assets $386,652  $337,608 
LIABILITIES AND STOCKHOLDERS' EQUITY        
CURRENT LIABILITIES:        
Accounts payable and accrued expenses $125,413  $140,854 
Accrued payroll to related parties  14,135   25,394 
SBA Loans  35,508   —   
Total Current Liabilities  175,056   166,248 
STOCKHOLDERS' EQUITY        
Common stock, 190,000,000 shares authorized at $0.001 par value, 29,924,544 and 29,351,294 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively  29,924   29,352 
Additional paid in capital  23,580,192   23,488,626 
Accumulated deficit  (23,398,521)  (23,346,618)
Total Stockholders' Equity  211,596   171,360 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $386,652  $337,608 
         
The accompanying notes are an integral part of these condensed financial statements.

 ii
 

 

MOJO ORGANICS, INC.
Condensed Balance Sheets (Unaudited)
As of September 30, 2019 and December 31, 2018
     
     
  September 30,
2019
 December 31, 2018
ASSETS  
CURRENT ASSETS:        
Cash and cash equivalents $5,346  $24,031 
Accounts receivable, net  133,649   128,342 
Inventory  169,758   159,531 
Supplier deposits  5,000   —   
Prepaid expenses  21,729   8,299 
Security deposit  4,518   4,518 
Total Current Assets $340,000  $324,720 
LIABILITIES AND STOCKHOLDERS' EQUITY        
CURRENT LIABILITIES:        
Accounts payable and accrued expenses $125,679  $109,931 
Accrued payroll to related parties  33,390   45,000 
Total Current Liabilities  159,069   154,931 
         
STOCKHOLDERS'EQUITY        
Common stock, 190,000,000 shares authorized at $0.001 par value, 28,910,356 and 26,667,781 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively  28,910   27,826 
Additional paid in capital  23,411,147   23,190,882 
Accumulated deficit  (23,259,126)  (23,048,919)
Total Stockholders'Equity  180,931   169,789 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $340,000  $324,720 
         
 The accompanying notes are an integral part of these condensed financial statements.

1

MOJO ORGANICS, INC.Condensed Statements of Operations (Unaudited)
For the Nine Months Ended September 30, 2019 and 2018
For the Six Months Ended June 30, 2020 and 2019For the Six Months Ended June 30, 2020 and 2019
  2019   2018   2020   2019 
Revenue $1,346,573  $1,283,086  $877,867  $843,235 
Cost of Revenue  692,219   696,604   446,462   430,113 
Gross Profit  654,354   586,482   431,505   413,122 
                
Operating Expenses                
Selling, general and administrative  864,562   864,427   483,633   588,705 
Total Operating Expenses  864,562   864,427 
        
Loss from Operations  (210,208)  (277,945)  (52,128)  (175,584)
Other Income  —     —     2,219   —   
        
Loss Before Provision for Income Taxes  (210,208)  (277,945)  (49,909)  (175,584)
Provision for Income Taxes  —     —     (1,994)  —   
Net Loss $(210,208) $(277,945) $(51,903) $(175,584)
Net loss per common share, basic and diluted $(0.00) $(0.01) $(0.00) $(0.01)
Basic and diluted weighted average number of common shares outstanding  28,431,664   27,011,460   29,690,570   28,565,224 
                
The accompanying notes are an integral part of these condensed financial statements. The accompanying notes are an integral part of these condensed financial statements. The accompanying notes are an integral part of these condensed financial statements.

   

 2 

 

MOJO ORGANICS, INC.
Condensed Statements of Operations (Unaudited)
For the Three Months Ended September 30, 2019 and 2018
 
 
   2019   2018 
Revenue $503,338  $489,778 
Cost of Revenue  262,106   254,251 
Gross Profit  241,232   235,526 
         
Operating Expenses        
Selling, general and administrative  275,857   374,722 
Total Operating Expenses  275,857   374,722 
         
Loss from Operations  (34,625)  (139,196)
Other Income  —     —   
         
Loss Before Provision for Income Taxes  (34,625)  (139,196)
Provision for Income Taxes  —     —   
Net Loss $(34,625) $(139,196)
Net loss per common share, basic and diluted $(0.00) $(0.01)
Basic and diluted weighted average number of common shares outstanding  29,623,689   27,250,188 
         
 The  accompanying notes are an integral part of these condensed financial statements.

MOJO ORGANICS, INC.
Condensed Statements of Operations (Unaudited)
For the Three Months Ended June 30, 2020 and 2019
 
   2020   2019 
Revenue $437,878  $434,738 
Cost of Revenue  209,412   229,480 
Gross Profit  228,465   205,257 
         
Operating Expenses        
Selling, general and administrative  223,981   302,694 
Income/(Loss) from Operations  4,485   (97,437)
Other Income  2,219   —   
Income/(Loss) Before Provision for Income Taxes  6,704   (97,437)
Provision for Income Taxes  (1,994)  —   
Net Income/(Loss) $4,710  $(97,437)
Net income/(loss) per common share, basic and diluted $0.00  $(0.00)
Basic and diluted weighted average number of common shares outstanding  29,889,203   28,699,846 
         
The accompanying notes are an integral part of these condensed financial statements.

   

 3 

 

 

MOJO ORGANICS, INC.MOJO ORGANICS, INC.MOJO ORGANICS, INC.
Condensed Statements of Cash Flows (Unaudited)Condensed Statements of Cash Flows (Unaudited)Condensed Statements of Cash Flows (Unaudited)
For the Nine Months Ended September 30, 2019 and 2018
For the Six Months Ended June 30, 2020 and 2019For the Six Months Ended June 30, 2020 and 2019
        
     2020 2019
  2019   2018     
Cash flows from operating activities:             
Net loss $(210,208) $(277,945) $(51,903) $(175,584)
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:        
Adjustments to reconcile net loss to net cash provided used in operating activities:     
Stock and warrants issued to directors and employees  222,100   188,824  97,389 154,390 
Changes in assets and liabilities:             
Increase in accounts receivable  (5,307)  (57,648) (21,540) (16,876)
(Decrease)/Increase in inventory  (10,227)  101,589 
Increase in inventory (37,424) (34,280
Increase in supplier deposits  (5,000)  (36,677) (27,461 (20,000)
(Increase)/Decrease in prepaid expenses  (13,430)  1,553 
Increase in accounts payable and accrued expenses  15,748   54,323 
Increase in prepaid expenses (3,720 (5,898)
(Decrease)/Increase in accounts payable and accrued expenses (17,435 80,257 
(Decrease)/Increase in accrued payroll to related parties  (11,610)  30,075   (11,259)  7,674 
Net cash (used in)/provided by operating activities  (17,934)  4,094 
        
Net cash used in operating activities (71,359 (10,317)
Net cash from financing activities:             
Proceeds from SBA Loan  35,508 - 
Shares repurchased for cancellation  (750)  (14,636)  (5,250)  (750)
Net cash used in financing activities  (750)  (14,636)
        
Net cash provided by/(used in) financing activities  30,258  (750)
Net decrease in cash and cash equivalents  (18,684)  (10,542) (41,101) (11,067)
Cash and cash equivalents at beginning of periods  24,031   22,357   55,978  24,031 
Cash and cash equivalents at end of periods $5,346  $11,815  $14,878 $12,963 
             

Summary of non-cash investing and financing activity: During the six-month period ended June 30, 2020 the Company issued a total of 598,250 Restricted and Non-Trading shares with an implied value of $97,389 to directors and officers to settle obligations payable. During the six-month period ended June 30, 2019 the Company issued a total of 744,000 Restricted and Non-Trading shares with a value of $154,390 to directors and officers to settle obligations payable.

Summary of non-cash investing and financing activity: During the six-month period ended June 30, 2020 the Company issued a total of 598,250 Restricted and Non-Trading shares with an implied value of $97,389 to directors and officers to settle obligations payable. During the six-month period ended June 30, 2019 the Company issued a total of 744,000 Restricted and Non-Trading shares with a value of $154,390 to directors and officers to settle obligations payable.

The accompanying notes are an integral part of these condensed financial statements

  

 4 

 

  

MOJO ORGANICS, INC.
Condensed Statements of Changes in Stockholders' Equity
For the Six Months Ended June 30, 2020
(Unaudited)
           
  Common Stock Additional Paid-In Accumulated Stockholders’
  Shares Amount Capital 
Deficit
 
Equity
           
Balance, January 1, 2020  29,351,294  $29,352  $23,488,626  $(23,346,618) $171,360 
Stock and warrants issued to Directors and Employees  598,250   598   96,791      97,389 
Stock repurchased and cancelled  (25,000)  (25)  (5,225)     (5,250)
Net loss        -   (51,903)  (51,903)
Balance, June 30, 2020  29,924,544  $29,924   23,580,192  $(23,398,521) $211,596 

 

MOJO ORGANICS, INC.
Condensed Statements of Changes in Stockholders' Equity
For the Nine Months Ended September 30, 2019
(Unaudited)
           
           
   Common Stock             
   Shares   Amount   

Additional Paid-In

Capital

   

Accumulated

Deficit

   

Stockholders’

Equity

 
Balance, January 1, 2019  27,825,773  $27,826  $23,190,822  $(23,048,918) $169,789 
Stock and warrants issued to Directors and Employees  1,088,750   1,089   221,011   —     222,100 
Stock repurchased and cancelled  (4,167)  (4)  (746)  —     (750)
Net loss  —     —     —     (210,208)  (210,208)
Balance, September 30, 2019  28,910,606  $28,910  $23,411,147  $(23,259,126) $180,930 
                     
The accompanying notes are an integral part of these condensed financial statements.
The accompanying notes are an integral part of these condensed financial statements.


 5 

 

 

MOJO ORGANICS, INC.

Notes to Condensed Financial Statements (Unaudited)

SeptemberJune 30, 20192020 

 

NOTE 1 – BUSINESS

 

Overview

 

MOJO Organics, Inc. (“MOJO” or the “Company”) is a Delaware corporation is headquartered in Jersey City, NJ. The Company engages in new product development, production, marketing, distribution and sales of beverage brands that are natural, Non-GMO Project verified, and Non GMO Project verified.USDA Organic. The CompanyCompany’s flagship product is MOJO Pure Coconut Water. In addition to Pure Coconut Water, the Company produces Sparkling Coconut Water, Coconut Water + Mango Juice and Coconut Water + Pineapple Juice. We seek to grow the market share of our products by expanding our hybrid distribution network through the relationships and efforts of our management and third party partners and improved broker network, and new products and packaging in 2020, including pH7 water (pH is a scale of acidity) and energy beverages which are both major sectors of the beverage industry. The Company sellscompany predominantly packages its productsbeverages in 100% recyclable, Eco-Friendly packaging that can be recycled infinite times and is not made from carbon oil based packaging. The packaging has a very low impact on the environment, and does not contribute to distributors, wholesalerslandfills and direct to consumers through e-commerce platforms.the pollution of our bodies of water. 

 

Interim Financial Statements

 

The accompanying unaudited interim condensed financial statements have been prepared pursuant to the rules and regulations for reporting on Form 10-Q and article 10 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, certain information and disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures included in these financial statements are adequate to make the information presented not misleading. The unaudited interim condensed financial statements included in this document have been prepared on the same basis as the annual audited financial statements, and in the Company’s opinion, reflect all adjustments necessary for a fair presentation in accordance with GAAP and SEC regulations for interim financial statements. The results for the ninethree months ended September 30, 2019March 31, 2020 are not necessarily indicative of the results that the Company will have for any subsequent period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and the notes to those statements for the year ended December 31, 20182019 included in the Company’s Annual Report on Form 10-K. 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates

 

The financial statements are prepared in conformity with GAAP. Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

Cash equivalents include investment instruments and time deposits purchased with a maturity of three months or less. As of SeptemberOn June 30, 20192020 and December 31, 2018,2019, the Company did not have any cash equivalents. For purposes of reporting cash flows, cash and cash equivalents include all highly liquid investments purchases with a maturity of three months or less.

Accounts Receivable

 

Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for doubtful accounts as of SeptemberJune 30, 20192020 and December 31, 20182019 was zero.

 

 6 

 

 

Inventories

 

Inventories, consisting solely of finished goods, are stated at the lower of cost (first-in, first-out method) or net realizable value.value (“NRV”). If necessary, the Company provides allowances to adjust the carrying value of its inventories to the lower of costNRV when NRV is below cost.There were no such adjustments in 2020 or NRV.2019.

 

Revenue Recognition

 

Revenue from sales of products is recognized when persuasive evidence of an arrangement exists,the related performance obligation is satisfied. The Company’s performance obligation is satisfied upon the shipment or delivery of products has occurred, theto customers. The Company’s products are sold on cash and credit terms which are established in accordance with standardized industry practices and typically require payment within 30 days of delivery. Costs incurred for sales price is fixed or determinableincentives and collectability is reasonably assured.discounts are accounted for as reductions in revenue.

 

Deductions from Revenue

 

Costs incurred for sales incentives and discounts are accounted for as reductions in revenue. These costs include payments to customers for performing merchandising activities on our behalf, including in store displays, promotions for new items and obtaining optimum shelf space.

 

Shipping and Handling Costs

 

Shipping and handling costs incurred to move finished goods from our sales distribution centers to customer locations are included in the line Selling, General and Administrative Expenses in our Statements of Operations.

  

Net LossIncome/(Loss) Per Common Share

 

The Company computes per share amounts in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260,“Earnings per Share”.ASC Topic 260 requires presentation of basic and diluted EPS. Basic EPS is computed by dividing the loss available to common stockholders by the weighted-average number of common shares outstanding for the period.  Diluted EPS is based on the weighted average number of shares of common stock and common stock equivalents outstanding during the periods.

 

The following potentially dilutive securities have been excluded from the computation of weighted average shares outstanding as they would have had an anti-dilutive impact on the Company’s net lossincome/(loss) per common share:

 

 At September 30,         As of June 30,
 2019 2018 Issued To Expiration Date No. of Days to Expiration Exercise Price 2020 2019
Shares underlying options outstanding  901,796   2,476,559  GLENN SIMPSON Apr   6, 2022  645  $0.16   505,608   901,796 
Shares underlying warrants outstanding  1,500,000   3,530,223  WYATTS TORCH Aug 19, 2020  50  $0.40   1,500,000   1,500,000 
Total  2,401,796   6,006,782               2,005,608   2,401,796 

 7 

 

Income Taxes

 

The Company provides for income taxes using the asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

 

The Company recognizes interest and penalties related to income tax matters in income tax expense. As of SeptemberJune 30, 20192020 and September 30, 2018,December 31, 2019, the Company had no accrued interest or penalties. The Company has had no Federal or stateState tax examinations in the past nor does it have any at the current time. As of SeptemberJune 30, 20192020 and December 31, 2018,2019, the Company had Net Operating Loss Carryforwards of $4,955,634approximately $4,660,000 and $4,736,851,$4,700,000, respectively, and recognized an Allowance for Deferred Tax Assets amounting to $1,295,155approximately $1,330,000 and $1,237,976, respectively.$1,320,000, respectively, which have been fully reserved by valuation allowances. The Company does not expect any significant reversals in the valuation allowance to be reversed within the next twelve months.

 

Stock-Based Compensation

 

The Company accounts for equity based transactions under the provisions of ASC Topic 718, “Accounting for Stock-Based Compensation”.The ASC prescribes accounting and reporting standards for stock-based compensation plans, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights. ASC Topic 718 requires employee compensation expense to be recorded using the fair value method.

 

Share based payment awards are measured at grant date fair valuethe month-end volume weighted average price (VWAP) of the equity instrument that an entity is obligated to issue when the service has been rendered and any other conditions necessary to earn the right to benefit from the instruments have been satisfied.

 

Fair value of financial instruments

 

The carrying amounts of financial instruments, which include cash, accounts receivable, accounts payable and accrued expense, approximate their fair values due to their short-term nature.

   

Recent Accounting Pronouncements

 

In MarchDecember 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2019-01,2019-12, Leases(Topic 842)Income Taxes (Topic 740): Codification Improvements”Simplifying the Accounting for Income Taxes”.The ASC aims to increase transparencyidentify, evaluate, and comparability among organizations by recognizing lease assetsimprove areas of generally accepted accounting principles (GAAP) for which cost and lease liabilities oncomplexity can be reduced while maintaining or improving the balance sheet and disclosing essentialusefulness of the information about leasing transactions.provided to users of financial statements. The Company has assessed thatis still assessing the impact of this pronouncement has no impact onto the financial statements.

 

 8 

 

 

NOTE 3 – COMMITMENTS AND CONTINGENCIES

 

The global coronavirus (COVID-19) pandemic has caused disruptions in supply chains, affecting production and sales across a range of industries. While this disruption is currently expected to be temporary, there is considerable uncertainty around the duration.

The extent of the impact of COVID-19 on our operational and financial performance will depend on the effect on our customers and vendors – all of which are uncertain and cannot be predicted. The related financial impact cannot be reasonably estimated at this time. 

Employment Agreements

 

On April 6, 2017, the Company entered into an Amended and Restated Employment AgreementsAgreement with Mr. Glenn Simpson (the “Simpson Agreement”), the Company’s Chairman and Chief Executive Officer (the “CEO”).The. The Simpson Agreement was effective April 1, 2017 and has an eight year term.

 

Pursuant to the Simpson Agreement dated April 6, 2017, Mr. Simpson will be paid a salary of $5,000 per month in cash and the right to receive 67,000 shares of restricted Common Stock per month. Pursuant to his employment agreement, Mr. Simpson is entitled to a salary of not less than $18,500 per month. Additionally, Mr. Simpson is entitled to an annual bonus comprised of cash and Common Stock based on the achievement of performance goals established by the Board of Directors of the Company asand set forth in the Simpson Agreement. The cash bonus is established at $44,400 per year. The stock bonus is set at 200,000 shares of Common Stock per year through May 31, 2025 based upon achieving revenue performance goals. The revenue goals range from $2,400,000$900,000 to $19,200,000 per year. The bonus awards are accelerated when revenues exceed the annual target amounts.

 

During the ninesix months ended SeptemberJune 30, 2019, 603,0002020, the CEO was issued 402,000 Restricted and Non-Trading shares of restricted Common Stock were issued tounder the CEO as partterms of the Simpson Agreement for the stock portion of his first second and thirdsecond quarter compensation. During 2018, hethe first quarter of 2020 and for the first and second quarters of 2019, Mr. Simpson did not receive cash payments. Mr. Simpson received stock in lieu of cash payments for the firstsecond quarter of 2018.2020. He was owed $33,390$5,000 and $45,000$10,000 as of SeptemberJune 30, 20192020 and December 31, 2018,2019, respectively, for the cash portion of his salary.

On December 8, 2017, the Company entered into an Amended and Restated Employment Agreement with Mr. Peter Spinner (the “Spinner Agreement”), who was the Company’s Chief Operating Officer at that date. This agreement was effective January 1, 2018. Pursuant to the Spinner Agreement, Mr. Spinner received $5,000 paid in stock each month for part-time employment.

The Spinner Agreement was terminated on March 31, 2018 when Mr. Spinner’s employment with MOJO ended.

 

The “Simpson Agreement” is the only executive employment agreement in effect as of SeptemberJune 30, 2019.2020.

 

The Company has no other plans in place and has never maintained any plans that provide for the payment of retirement benefits or benefits that will be paid primarily following retirement including, but not limited to, tax qualified deferred benefit plans, supplemental executive retirement plans, tax-qualified deferred contribution plans and nonqualified deferred contribution plans.

 

 9 

 

 

Lease Commitment

 

The Company maintains office space in Jersey City, NJ. The initial lease agreement was for the period March 1, 20182019 to February 28, 201929, 2020 and was renewed for one year (through February 29, 2020)under the same terms. In April 2020, the Company was given a 50% discount on the rent for April and May 2020 as well as an optional lease extension for an additional three months under the same terms. The base rent under this agreement is $2,304$2,343 per month.month, and expires May 31, 2021. Lease expense amounted to $20,736$4,686 and $20,682$6,912 for the ninesix months ended SeptemberJune 30, 20192020 and 20182019 respectively. The security deposit for the lease agreement is $4,518 and the lease expires on February 29, 2020.May 31, 2021.

 

NOTE 4 – STOCKHOLDERS’ EQUITY

 

The Company has authorized 190,000,000 shares of Common Stock having a par value of $0.001. On February 4, 2019, the Company by a vote of its majority shareholders cancelled the authorization for the issuance of up to 10,000,000 shares of preferred stock. There were no shares of preferred stock issued or outstanding prior to this change.

Common Stock outstanding at June 30, 2020 and December 31, 2019 includes a total of 367,204 restricted shares issued in certificate form to a former consultant which were ordered cancelled during 2014. Such shares cannot be cancelled until the physical shares are surrendered to the Company or the Company’s designee and are not otherwise transferable by the holder.

 

Restricted Stock Issuances

During the six months ended June 30, 2020, 598,250 shares of Restricted and Non-Trading Common Stock were issued to Directors and Officers of the Company. These shares have full voting rights but are restricted for sale or transfer. The CEO exercised options to purchase 156,250 shares at $0.16 per share for a total exercise price of $25,000 which reduced the accrued salary payable to the CEO by the same amount. The CEO was also issued 402,000 shares of Restricted and Non-Trading Common Stock for the stock portion of his salary for the first and second quarter. A Director was issued 40,000 shares of Common stock as an award for continuing to serve as a Director of the Company. The value of these shares was recorded as a component of compensation expense.

Stock Warrants

In connection with private placement offerings in March 2014 (the “2014 Offerings”), warrants to purchase 2,030,223 shares of Common Stock were issued at a price of $0.91 per share. These warrants expired on March 12, 2019.

In connection with a private placement offering in August 2015 (the “2015 Offerings), warrants to purchase 1,500,000 shares of Common Stock were issued at a price of $0.40 per share. These warrants will expire on August 19, 2020.

The following table summarizes warrant activity during the period:

  

 

Issued To

 Expiration Date No. of Days to Expiration Exercise Price 

 

Options

Issued August 19, 2015 WYATTS TORCH Aug 19, 2020  1,828  $0.40   1,500,000 
Outstanding, June 30, 2020 WYATTS TORCH Aug 19, 2020  50  $0.40   1,500,000 
Exercisable, June 30, 2020 WYATTS TORCH Aug 19, 2020  50  $0.40   1,500,000 

Stock Purchased for Cancellation

On January 23, 2020 the Company purchased 25,000 shares of its restricted common stock from one shareholder for cancellation. The Company paid $5,250 or $0.21 per share which was the average market price for its traded shares during the period. The shares were cancelled and are available for reissuance.

10

NOTE 5 – STOCKOPTIONS

On April 6, 2017, the Company granted stock options to purchase 356,559 shares and 1,500,000 shares of Common Stock pursuant to the 2012 Incentive Plan and the 2015 Incentive Plan, respectively. The options were priced at the fair market value of the Common Stock and are immediately exercisable.

2012 Incentive Plan

 

The 2012 Incentive Plan was terminated by the Board of Directors onOn February 18, 2019. The2019, the Company’s Board of Directors resolved thatsigned an unanimous consent to terminate the 2012 Incentive Plan, which allowed the issuance of up to 2,050,000 securities to officers, directors and consultants as incentive compensation would be terminated. Itit was resolved further resolved that 70,000 options to purchase shares of common stock issued under the 2012 Incentive PlanCommon Stock be converted into 70,000 shares of Common Stock. Another resolution was made that Mr. Glenn Simpson be permittedIt also consented the CEO of the Company to exercise his optionoptions to purchase 222,000 Restricted and Non-Trading shares of Common Stock forat $0.255 per share. The total exercise price was $56,610 and this reduced the loan payable to the CEO by the same amount.

 

The 2012 Incentive Plan was approved by our shareholders in March 2013. The 2012 Incentive Plan provided the Company with the ability to issue stock options, stock appreciation rights, restricted stock and/or other stock-based awards for up to an aggregate of 2,050,000 shares of common stock.  In 2016, the Company issued 620,000 stock options to purchase shares of common stock that expire in August 2019, and issued 1,073,441,restricted common stock to its Directors and employees. In 2017, the Company granted stock options to purchase 356,559 shares that expire in April 2022. The options were priced at the fair market value of the Common Stock and are exercisable. In 2018, there were no issuances under the 2012 plan. As of December 31, 2018, issued stock options total 976,559. During 2018, 495,403 stock options had been cancelled due to termination of employment and were available for reissuance at that time. There are no options outstanding from this plan as of June 30, 2020 and December 31, 2019.

 

2015 Incentive Plan

 

The 2015 Incentive Plan was terminated by the Board of Directors on January 24, 2019. The 2015 Incentive Plan provided the Company with the ability to issue stock options, stock awards and/or restricted stock purchase offers for up to an aggregate of 1,500,000 shares of Common Stock.

 

The Company approved the 2015 Incentive Plan in October 2015. The 2015 Incentive Plan provided the Company with the ability to issue stock options, stock awards and/or restricted stock purchase offers for up to an aggregate of 1,500,000 shares of Common Stock. In April, 2017, the Company granted stock options to purchase 1,500,000 shares of Common Stock pursuant to the 2015 Plan. The options were priced at the fair market value of the Common Stock and were exercisable from the date of issuance. In 2018, there were no issuances under the 2015 plan. As of December 31, 2018, issued stock options total 1,500,000. During 2018, 693,610 stock options had been cancelled due to termination of employment and were available for reissuance at that time.

Restricted Stock Compensation

On May 9, 2018, the Company’s Board There are 505,609 options outstanding from this plan as of Directors approved to the lifting of the prior restrictions on 8,756,542, shares issued to the CEO and 4,709,022, shares issued to the former COO of the Company. 

10

Restricted Stock Issuances

During the nine months ended September 30, 2019, 1,088,750 shares of restricted Common Stock were issued to Directors and Officers of the Company. These shares have full voting rights but are restricted for sale or transfer.

During the quarter ended March 31, 2019, a total of 493,000 shares of restricted Common Stock were issued. The CEO exercised his option to purchase 222,000 shares at $0.255 per share. The CEO was also issued 201,000 shares for the stock portion of his salary for the first quarter. Two directors who had 35,000 options each were issued a total of 70,000 shares of Common Stock following the resolution to terminate the 2012 Incentive Plan as discussed in Note 4.

During the quarter ended June 30, 2019, a total2020, and 661,858 options outstanding as of 251,000 shares of restricted Common Stock were issued. 201,000 shares were issued to the CEO for the stock portion of his salary for the second quarter and 50,000 shares were issued to the Corporate Controller as part of her annual stock bonus.

During the quarter ended September 30, 2019, a total of 344,750 shares of restricted Common Stock were issued. The CEO exercised his option to purchase 93,750 shares at $0.16 per share. The total exercise value is $15,000 and this reduced the loan payable balance to the CEO to $0. The CEO was also issued 201,000 shares for the stock portion of his salary for the third quarter. The Corporate Controller was also issued 50,000 shares as part of her annual stock bonus.

11

Stock Warrants

In connection with private placement offerings in March 2014 (the “2014 Offerings”), warrants to purchase 2,030,223 shares of Common Stock were issued at a price of $0.91 per share. These warrants expired on March 12,December 31, 2019.

 

In connection with the February 2016 Private Placement Offering, warrants to purchase 482,143 shares of Common Stock were issued at a price of $0.70 per share, these warrants expired on February 12, 2018.Option Activity

The following table summarizes warrant activity during the period:

Outstanding at December 31, 20183,530,223
Expired in March 2019(2,030,223)
Outstanding at September 30, 20191,500,000
Exercisable at September 30, 20191,500,000

 

  Number of Warrants Expiration Date Exercise Price Exercise Value
Issued August 19, 2015  1,500,000  August 19, 2020 $0.40  $600,000 
Exercisable at September, 2019  1,500,000           

Advisory Services

On October 3, 2013, the Company entered into an agreement for strategic business advisory services, public relations services and investor relations services with Ian Thompson from Carricklee House, Strabane, Northern Ireland.  

In connection with this agreement, the Company issued 167,204 shares of restricted Common Stock and recorded consulting fees of $501,612 during 2013, which was the fair market value of the stock on the date of issue.  The stock is vested; however it is restricted from trading. Ian Thompson was also issued 200,000 shares of restricted Common Stock, which was to vest quarterly based upon the Company reaching certain market capitalization and revenue goals, in addition to providing the above services, with the last tranche vesting on June 30, 2014. Consulting fees amounting to $105,000 and $280,000 were recorded in 2014 and 2013, respectively, related to the 200,000 shares of Common Stock.  Throughout the term of the agreement, the Company requested that Ian Thompson to render performance under the agreement and to provide evidence of same. Ian Thompson failed to perform in all material respects under the terms of the agreement and refused to provide evidence.

12

On June 27, 2014, the Company terminated the agreement.  Empire Stock Transfer, Inc, the Company’s transfer agent was directed to process cancellation requests regarding the certificates listed below. The Board of Directors approved the Company’s irrevocable agreement to indemnify the Transfer Agent for all loss, liability or expense in carrying out the authority and direction contained on the terms of the Unanimous Written Consent to terminate the Thompson Agreement. The Transfer Agent shall maintain the right to uphold the transfer in the event of forgery.

Certificate No(s) Registered To No. of Shares Transfer to or CANCELLED No. of Shares
 605  Ian Thompson  50,000  CANCELLED  50,000 
 606  Ian Thompson  50,000  CANCELLED  50,000 
 607  Ian Thompson  50,000  CANCELLED  50,000 
 608  Ian Thompson  50,000  CANCELLED  50,000 
 610  Ian Thompson  167,204  CANCELLED  167,204 

Stock Purchased for Cancellation

During the period January 1, 2019 to September 30, 2019, the Company purchased 4,167 shares of its restricted common stock from one shareholder for cancellation. The Company paid $750 which was the market price for its traded shares during the period. The shares were cancelled and are available for reissuance.

NOTE 5 – STOCKOPTIONS

On April 6, 2017, the Company granted stock options to purchase 356,559 shares and 1,500,000 shares of Common Stock pursuant to the 2012 Incentive Plan and the 2015 Incentive Plan, respectively. See note 4. The options were priced at the fair market value of the Common Stock and are immediately exercisable.

On March 31,2018, 1,189,013 stock options were forfeited due to a termination of employment.

On February 18, 2019, the Company’s Board of Directors resolved to terminate the 2012 Incentive Plan, and it was resolved further that 70,000 options to purchase shares of Common Stock be converted into 70,000 shares of Common Stock. It also allowed the CEO of the Company to exercise his option to purchase 222,000 shares of Common Stock.

During February 2019, two of the Company’s Directors surrendered 70,000 stock options and were issued 70,000 shares of Common Stock in exchange. The CEO of the Company was also issued 222,000 Restricted and Non-Trading shares of Common Stock.

 

On August 13, 2019, the Company’s Board of Directors resolved to allowconsented the CEO to exercise his optionoptions to purchase 93,750 Restricted and Non-Trading shares at $0.16 per share. The total exercise value of $15,000 was reduced the loan payable to the CEO to $0.

 

On November 1, 2019, the Company’s Board of Directors consented the CEO to exercise options to purchase 239,938 Restricted and Non-Trading shares at $0.16 per share. The total exercise value of $38,390 was reduced the accrued salary payable to the CEO by the same amount.

11

As of September 30,December 31, 2019, there are 901,796 remaining661,858 options outstanding that were issued to Glenn Simpson. The weighted average exercise price is $0.16.

On January 14, 2020 the Company’s Board of Directors consented the CEO to exercise options to purchase 93,750 Restricted and Non-trading shares at $0.16 per share. The total exercise value of $15,000 was reduced the accrued salary payable to the CEO by the same amount.

On March 6, 2020 the Company’s Board of Directors consented the CEO to exercise options to purchase 62,500 Restricted and Non-Trading shares at $0.16 per share. The total exercise value was $10,000 and this reduced the accrued salary payable to the CEO to $0. 

 

The following table summarizes stock option activity under the Plans:

 

  Options 

Weighted Average

Exercise Price

 Weighted Average Remaining Contractual Term (in years)
Outstanding, December 31, 2018  1,287,546  $0.182   2.69 
Granted            
Exercised  (315,750)  0.227   —   
Forfeited  (70,000)  0.255   —   
Outstanding, September 30, 2019  901,796  $0.160   2.52 
Exercisable, September 30, 2019  901,796  $0.160   2.52 

 

  

 

 

Issued To

 

 

 

Expiration Date

 No. of Days to Expiration 

 

Exercise Price

 

 

 

Options

Outstanding, December 31, 2019 GLENN SIMPSON 4/6/2022  827  $0.16   661,858 
Exercised GLENN SIMPSON 4/6/2022  736  $0.16   (156,250)
Outstanding, June 30, 2020 GLENN SIMPSON 4/6/2022  645  $0.16   505,608 
Exercisable, June 30, 2020 GLENN SIMPSON 4/6/2022  645  $0.16   505,608 

 

During the ninesix months ended SeptemberJune 30, 20192020 and 2018,2019, compensation expense related to stock options of $0 and $0, respectively, was recorded.$0. As of SeptemberJune 30, 2019,2020, there was no unrecognized compensation cost related to non-vested stock options.

 

 1312 

 

 

NOTE 6 – RELATED PARTY TRANSACTIONS

On February 25, 2019January 14, 2020 the CEO of the Company exercised 222,00093,750 stock options at an exercise price of $0.255$0.16. The Company issued 93,750 Restricted and Non-Trading shares of Common Stock, and the accrued payroll owed to him was reduced by $56,610.$15,000.

 

On August 13, 2019March 12, 2020 the $15,000 loan payable$10,000 accrued salary balance was used to pay for an option exercise made by the CEO of the Company. As a result of the transaction, the Company issued 93,75062,500 Restricted and Non-Trading shares of Common Stock to the CEO and the balance payable underaccrued payroll then owed to the loanCEO was reduced to $0.

 

As of SeptemberJune 30, 2019,2020, accrued payroll of $48,784$14,135 was owed to the CEO and employees.the Controller of the Company.

NOTE 7 – SBA LOANS “CARES ACT”

On May 5, 2020, the Company received loan proceeds in the amount of $35,508 under the Paycheck Protection Program (“PPP”).  The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”), provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The loans and accrued interest are forgivable after eight weeks as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees or reduces salaries during the eight-week period.

If there were an unforgiven portion of the PPP loan, it would be payable over a period of up to two years at an interest rate of 1%, with a deferral of payments for the first six months.  The Company’s use of the proceeds is consistent with the PPP. The Company believes that its use of the loan proceeds has met the criteria for forgiveness of the loan. The Company believes that the loan will be forgiven on November 1, 2020 or sooner in accordance with the guidance from the PPP.

On May 27, 2020, the Company received grant proceeds in the amount of $2,000 under the Economic Injury Disaster Loan (“EIDL”) Program. The EIDL program was created to assist businesses, renters and homeowners located in regions affected by declared disasters. The Company applied for the EIDL Emergency Advance which provides $1,000 per employee up to a maximum of $10,000.

The EIDL Advances are 100% forgivable as long as it is used for providing sick leave benefits to employees, maintaining payroll to retain employees, payments on mortgage, rent and utilities, increased costs to obtain materials from the applicants original source due to interrupted supply chains, and repaying obligations that cannot be met due to revenue losses. The Company’s use of the advance has met the criteria for forgiveness of the advance.

 

 1413 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided in addition to the accompanying financial statements and notes to assist readers in understanding our results of operations, financial condition and cash flows. MD&A is organized as follows:

 

Significant Accounting Policies — Accounting policies that we believe are important to understanding the assumptions and judgments incorporated in our reported financial results and forecasts.

 

Results of Operations — Analysis of our financial results comparing the ninesix months ended SeptemberJune 30, 20192020 to SeptemberJune 30, 2018.2019.

 

Results of Operations — Analysis of our financial results comparing the three months ended SeptemberJune 30, 20192020 to SeptemberJune 30, 2018.2019.

 

Liquidity and Capital Resources — Analysis of changes in our cash flows, and discussion of our financial condition and potential sources of liquidity.

 

This report includes a number of forward looking statements that reflect our current views with respect to future events and financial performance.  Forward looking statements are often identified by words like: believe, expect, estimate, anticipate, intend, project and similar expressions, or words which, by their nature, refer to future events.  You should not place undue certainty on these forward looking statements, which apply only as of the date of this annual report.  These forward looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or our predictions.

 

Significant Accounting Policies

 

We have prepared our financial statements in conformity with accounting principles generally accepted in the United States, which requires management to make significant judgments and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. We base these significant judgments and estimates on historical experience and other applicable assumptions we believe to be reasonable based upon information presently available. These estimates may change as new events occur, as additional information is obtained and as our operating environment changes. These changes have historically been minor and have been included in the financial statements as soon as they became known. Actual results could materially differ from our estimates under different assumptions, judgments or conditions.

 

All of our significant accounting policies are discussed in Note 2, Summary of Significant Accounting Policies, to our financial statements, included elsewhere in this Annual Report. We have identified the following as our critical accounting policies and estimates, which are defined as those that are reflective of significant judgments and uncertainties, are the most pervasive and important to the presentation of our financial condition and results of operations and could potentially result in materially different results under different assumptions, judgments or conditions.

 

We believe the following critical accounting policies reflect our more significant estimates and assumptions used in the preparation of our financial statements:

 

Use of Estimates — The financial statements are prepared in conformity with accounting principles generally accepted in the United States ("GAAP"). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Stock-based Compensation — ASC Topic 718, “Accounting for Stock-Based Compensation” prescribes accounting and reporting standards for employee stock-based compensation plans, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights. 

 1514 

 

 

ASC Topic 718 requires employee compensation expense to be recorded using the fair value method. The Company accounts for employee stock based compensation in accordance with the provisions of ASC Topic 718.Recent Accounting Pronouncements

 

Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility. The Company uses the Black-Scholes option-pricing option model to value its stock option awards which incorporate the Company’s stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life.

Recent Accounting Pronouncements

New Accounting Pronouncements

 

In MarchDecember 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2019-01,2019-12, Leases(Topic 842)Income Taxes (Topic 740): Codification Improvements”Simplifying the Accounting for Income Taxes”.The ASC aims to increase transparencyidentify, evaluate, and comparability among organizations by recognizing lease assetsimprove areas of generally accepted accounting principles (GAAP) for which cost and lease liabilities oncomplexity can be reduced while maintaining or improving the balance sheet and disclosing essentialusefulness of the information about leasing transactions.provided to users of financial statements. The Company has assessed thatis still assessing the impact of this pronouncement has no impact onto the financial statements.

 

COMPANY OVERVIEW

 

MOJO Organics, Inc. (“MOJO” or the “Company”) is a Delaware Corporation is headquartered in Jersey City, NJ. The Company engages in new product development, production, marketing, distribution and sales of beverage brands that are Non GMONon-GMO Project Verified.

 

The Company’s flagship product is MOJO Pure Coconut Water. In addition to Pure Coconut Water, the Company produces Sparkling Coconut Water, Coconut Water + Mango Juice and Coconut Water + Pineapple Juice. We seek to grow the market share of our products by expanding our hybrid distribution network through the relationships and efforts of our management and third party partners and improved broker network, and new products and packaging in 2020, including pH7 water (pH is a scale of acidity) and energy beverages which are both major sectors of the beverage industry. The company predominantly packages its beverages in 100% recyclable, Eco-Friendly packaging that can be recycled infinite times and is not made from carbon oil based packaging. The packaging has a very low impact on the environment, and does not contribute to landfills and the pollution of our bodies of water.  

Results of Operations

 

NineSix Months Ended SeptemberJune 30, 20192020 and 20182019

 

Revenue

 

For the ninesix months ended SeptemberJune 30, 2019,2020, the Company reported revenue of $1,346,573,$877,967 an increase of $ 63,487$34,732 or 5%4% from revenue of $1,283,086$843,235 for the ninesix months ended SeptemberJune 30, 2018.2019.  The increase in revenue was primarily due to the growinghigher demand for MOJO branded products. Cases sold for MOJO products in the first and second quarters of 2020 increased by 3,856 compared to a lesser extent private label products.the same period in 2019.

 

Cost of Revenue

 

Cost of revenue includes finished goods purchase costs, production costs, raw material costs and freight in costs. Also included in cost of revenue are adjustments made to inventory carrying amounts, including markdowns to market.

 

For the ninesix months ended SeptemberJune 30, 2020, cost of revenue was $446,462 or 51% of revenue. For the six months ended June 30, 2019, cost of revenue was $692,219$430,113 or 51% of revenue. For the nine months ended September 30, 2018,The cost of revenue perception was $696,604 or 54%the same for both periods.

Operating Expenses

For the six months ended June 30, 2020, operating expenses were $483,633, a decrease of revenue. The 3 percentage points$105,072 from operating expenses of $588,705 for the six months ended June 30, 2019.

This decrease in operating expenses was primarily due tocomprised of lower purchase price of goodsselling expenses and lower compensation expenses. Selling expenses were $220,078 for the six months ended June 30, 2020 compared to $254,230 for the six months ended June 30, 2019. This $34,152 decrease is attributable to the lower freight in costs.and delivery expenses and storage fees.

 

 1615 

 

 

Operating Expenses

For the nine months ended September 30, 2019, operating expensesThere were $864,562 an increase of $135 from operating expenses of $864,427 for the nine months ended September 30, 2018.

This increase in operating expenses was comprised of higher selling expenses offset by lower compensation expensesno trade show fees recorded and consulting fees. Selling expenses were $350,061 for the nine months ended September 30, 2019 compared to $289,015 for the nine months ended September 30, 2018. This $61,045 increase is attributable to the Amazon sellingmarketing fees coupled with an increase in freight and delivery expenses. Total compensation expense decreased by $10,308$8,473 from the same period last year, while consulting feesyear. Compensation expense also decreased by $50,683 due$60,291 compared to termination of consulting agreements in 2018.the same period last year.

 

Three Months Ended SeptemberJune 30, 20192020 and 20182019

 

Revenue

 

For the three months ended SeptemberJune 30, 2019,2020, the Company reported revenue of $503,338,$437,878, an increase of $13,560$ 3,140 or 3%1% from revenue of $489,778$434,738 for the three months ended SeptemberJune 30, 2018.2019.  The increase in revenue was due to lower deductions from revenue during 2020 compared to the new private label orders that MOJO fulfilled during the quarter.same period last year.

 

Cost of Revenue

 

Cost of revenue includes finished goods purchase costs, production costs, raw material costs and freight in costs. Also included in cost of revenue are adjustments made to inventory carrying amounts, including markdowns to market.

 

For the three months ended SeptemberJune 30, 2019,2020, cost of revenue was $262,106$209,412 or 52%48% of revenue. For the three months ended SeptemberJune 30, 2018,2019, cost of revenue was $254,251$229,480 or 52%53% of revenue. The Company5 percentage point decrease was ableprimarily due to maintain the same cost ratio from the same period last year.lower costs of packaging material and lower freight in costs.

 

Operating Expenses

 

For the three months ended SeptemberJune 30, 2019,2020, operating expenses were $275,857$223,981 a decrease of $98,865$78,713 from operating expenses of $374,722$302,694 for the three months ended SeptemberJune 30, 2018.2019.

 

TheThis decrease in operating expenses was comprised of lower selling expenses as well as lower compensation costs and consulting expenses. Selling expenses were $108,331$105,132 for the three months ended SeptemberJune 30, 20192020 compared to $122,850$121,435 for the ninethree months ended SeptemberJune 30, 2018.2019. This $14,519$16,303 decrease is attributable to the lower storage fees and warehouse processing fees offset by an increase in freight and delivery expenses.expenses and reduced storage and warehousing fees. Compensation expensesexpense also decreased by $6,747$60,289 from $126,827 in 2018 while consulting fees decreased by $50,683$137,470 for the same period last year.quarter ended June 30, 2020.

 

16

Liquidity and Capital Resources

 

Liquidity

 

As of SeptemberJune 30, 2019,2020, the Company had working capital of $180,930.$213,590. Net cash used forin operating activities was $17,934$71,359 for the ninesix months ended SeptemberJune 30, 2019, a decrease2020, an increase of $22,028$61,041 compared to $10,317 net cash derived from operating activitiesused for the ninesix months ended SeptemberJune 30, 2018.2019. Net cash provided by financing activities was $30,258 for the six months ended June 30, 2020 compared to net cash used in financing activities wasof $750 for the ninesix months ended SeptemberJune 30, 2019 and $14,636 for the nine months ended September 30, 2018.2019.

 

Working Capital Needs

 

Our working capital requirements increase as demand grows for our products. Should the Company require additional working capital in the next twelve months, it may seek to raise funds.  Financing transactions could include the issuance of equity or debt securities or obtaining credit facilities. The Company has not required additional financing since February 2016.

  

OFF-BALANCE SHEET ARRANGEMENTS

 

The Company had no off-balance sheet arrangements as of SeptemberJune 30, 2019.2020  

 

 17 

 

 

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISKS

 

Not applicable.

 

ITEM 4.  CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act of 1934 (the “Exchange Act”) is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. It should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

 

Under the supervision and with the participation of the Company’s senior management, consisting of the Company’s principal executive and financial officer and the Company’s principal accounting officer, the Company conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, the Company’s principal executive and financial officer concluded, as of the Evaluation Date, that the Company’s disclosure controls and procedures were effective.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

The management of MOJO Organics, Inc. is responsible for establishing and maintaining an adequate system of internal control over financial reporting (as defined in Rule 13a-15(f)) under the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes of accounting principles generally accepted in the United States. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.

 

Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. In evaluating the effectiveness of our internal control over financial reporting, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on this evaluation, our officers concluded that, during the period covered by this annual report, our internal controls over financial reporting were operating effectively.

 

Changes in Internal Control over Financial Reporting

 

There was no change in our internal controls over financial reporting during the ninesix months ended SeptemberJune 30, 20192020 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

 18 

 

 

PART II – OTHER INFORMATION

  

ITEM 1.  LEGAL PROCEEDINGS

 

We are currently not a party to any material legal or administrative proceedings and are not aware of any pending or threatened material legal or administrative proceedings arising in the ordinary course of business.  We may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business.

 

ITEM 1A.  RISK FACTORS

 

AsThe global coronavirus (COVID-19) pandemic has caused disruptions in supply chains, affecting production and sales across a smaller reporting company, as defined in Rule 12b-2range of industries. While this disruption is currently expected to be temporary, there is considerable uncertainty around the duration.

The extent of the Exchange Act, weimpact of COVID-19 on our operational and financial performance will depend on the effect on our customers and vendors – all of which are not required to provide the information required byuncertain and cannot be predicted. The related financial impact cannot be reasonably estimated at this Item.time. 

   

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

  

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

 

None. 

 

ITEM 4.  MINE SAFETY DISCLOSURE

 

Not applicable.

 

ITEM 5.  OTHER INFORMATION

 

None. 

 

 19 

 

 

ITEM 6.  EXHIBITS

 

Exhibit No.SEC Report Reference NumberDescriptionSEC Report Reference NumberDescription
2.1Agreement and Plan of Merger by and among Specialty Beverage and Supplement, Inc., SBSI Acquisition Corp.  and MOJO Ventures, Inc. dated May 13, 2011 (1)
2.22.1Split-Off Agreement, dated as of October 27, 2011, by and among MOJO Ventures, Inc., SBSI Acquisition Corp., MOJO Organics, Inc., and the Buyers party thereto (2)
3.13.1Certificate of Incorporation of MOJO Shopping, Inc. (3)3.1Certificate of Incorporation of MOJO Shopping, Inc. (3)
3.23.1Amendment to Certificate of Incorporation of MOJO Ventures, Inc. (4)3.1Amendment to Certificate of Incorporation of MOJO Ventures, Inc. (4)
3.33.1Certificate of Amendment to Certificate of Incorporation of MOJO Ventures, Inc. (5)3.1Certificate of Amendment to Certificate of Incorporation of MOJO Ventures, Inc. (5)
3.43.4Articles of Merger (1)3.4Articles of Merger (1)
3.53.1Certificate of Amendment to Certificate of Incorporation of MOJO Organics, Inc. (9)3.1Certificate of Amendment to Certificate of Incorporation of MOJO Organics, Inc. (9)
3.63.1Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock (11)3.1Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock (11)
3.73.1Amended and Restated Bylaws of MOJO Ventures, Inc. (6)3.1Amended and Restated Bylaws of MOJO Ventures, Inc. (6)
3.83.8Amendment No. 1 to Amended and Restated Bylaws of MOJO Organics, Inc. (13)3.8Amendment No. 1 to Amended and Restated Bylaws of MOJO Organics, Inc. (13)
10.110.1Form of Second Amended and Restated Restricted Stock Agreement (14)10.1Form of Second Amended and Restated Restricted Stock Agreement (14)
10.210.62012 Long-Term Incentive Equity Plan (13)10.62012 Long-Term Incentive Equity Plan (13)
10.310.7Form of Stock Option Agreement under the 2012 Long-Term Incentive Equity Plan (13) †10.7Form of Stock Option Agreement under the 2012 Long-Term Incentive Equity Plan (13) †
10.410.8Form of Indemnification Agreement with officers and directors (13)10.8Form of Indemnification Agreement with officers and directors (13)
10.510.1Form of Promissory Note issued to OmniView Capital LLC and Paul Sweeney (11)10.1Form of Promissory Note issued to OmniView Capital LLC and Paul Sweeney (11)
10.610.2Advisor Agreement with OmniView Capital LLC (11)10.2Advisor Agreement with OmniView Capital LLC (11)
10.710.3Amended and Restated Securities Purchase Agreement (11)10.3Amended and Restated Securities Purchase Agreement (11)
10.810.4Registration Rights Agreement (11)10.4Registration Rights Agreement (11)
10.910.5Commitment letter executed by each of Glenn Simpson, Jeffrey Devlin and Richard Seet (11)10.5Commitment letter executed by each of Glenn Simpson, Jeffrey Devlin and Richard Seet (11)
10.1010.6Amendment to Richard X. Seet Restricted Stock Agreement (11)10.6Amendment to Richard X. Seet Restricted Stock Agreement (11)
10.1110.7Letter Agreement relating to nominee right of OmniView Capital LLC (11)10.7Letter Agreement relating to nominee right of OmniView Capital LLC (11)
10.1210.1Juice License Agreement between Chiquita Brands L.L.C. and MOJO Organics, Inc. dated as of August 15, 2012 (12)
10.1310.17Form of Subscription Agreement for 2013 Offering (13)
10.1410.18Employment Agreement dated March 1, 2013 between MOJO Organics, Inc. and Glenn Simpson (13) †

10.15

10.15Form of Advisor Agreement (14)
10.16Form of Restricted Stock Agreement, dated December 4, 2014, between MOJO Organics, Inc. and each of Glenn Simpson, Richard Seet, Jeffrey Devlin and Nicholas Giannuzzi.  (14) †
10.17Form of Restricted Stock Agreement, dated March 2014, between MOJO Organics, Inc. and each of Glenn Simpson, Richard Seet, Jeffrey Devlin, Peter Spinner and Marianne Vignone. (14) †
10.18Form of Subscription Agreement for March 2014 Stock (with Warrants) Offering (14)
10.19Form of Warrant (14)
10.20Form of Subscription Agreement for March 2014 Stock Offering (14)
10.21Form of Distribution Agreement
10.2210.2Form of Stock Option Agreement under the 2012 Long-Term Incentive Equity Plan, dated August 14, 2014, between MOJO Organics, Inc. and each of Glenn Simpson, Peter Spinner, Richard Seet, Jeffery Devlin and Marianne Vignone. (15)
10.2310.3Employment Agreement, dated August 12, 2014, between MOJO Organics, Inc. and Peter Spinner. (15)
10.2410.1Form of Restricted Stock Agreement, dated August 12, 2014, between MOJO organics, Inc. and Peter Spinner. (15)
10.25Amended and Restated Employment Agreement by and between MOJO Organics, Inc. and Glenn Simpson dated June 15, 2015 (16)
10.26Amended and Restated Employment Agreement by and between MOJO Organics, Inc. and Peter Spinner dated June 15, 2015 (16)
10.2710.1Letter Agreement by and between MOJO Organics Inc. and Peter Spinner dated December 15, 2015(18)
10.2810.1Common Stock Purchase Agreement by and between MOJO Organics, Inc. and Wyatts Torch Equity Partners, LP dated March 6, 2017
16.1Letter from Liggett, Vogt & Webb, P.A. (16)
16.216.1Letter from Cowan, Gunteski & Co., P.C. dated April 21, 2016 (19)
31.131.1Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 200231.1Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.132.1Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 200232.1Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

  

*  Filed herewith.

† Management compensatory plan, contract or arrangement.

  

20

 (1)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the Securities and Exchange Commission (the “SEC”) on May 18, 2011.

 

 (2)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on November 2, 2011.

(3)Incorporated by reference to the Registrant's Registration Statement on Form SB-2 as an exhibit, numbered as indicated above, filed with the SEC on December 19, 2007.

 

 (4)(3)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on May 4, 2011.

 

 (5)(4)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on January 4, 2012.

 

 (6)(5)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on October 31, 2011.

 

 (7)(6)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on August 12, 2011.

  

 (8)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on June 8, 2011.

(9)(7)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on April 2, 2013.

 

 (10)Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q as an exhibit, numbered as indicated above, filed with the SEC on June 25, 2013.

(11)(8)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on February 1, 2013.

 

 (12)(9)Incorporated by reference to the Registrant’s Current Report on Form 8-K/A as an exhibit, numbered as indicated above, filed with the SEC on February 7, 2013.  Portions of the exhibit and/or related schedules or exhibits thereto have been omitted pursuant to a request for confidential treatment, which has been granted by the Commission. 

 

 (13)(10)Incorporated by reference to the Registrant’s Current Report on Form 10-K as an exhibit, numbered as indicated above, filed with the SEC on September 24, 2013.

 

 (14)Incorporated by reference to the Registrant’s Annual Report on Form 10-K as an exhibit, numbered as indicated above, filed with the SEC on April 16, 2014.

(15)(11)Incorporated by reference to the Registrant’s Annual Report on Form 10-Q as an exhibit, numbered as indicated above, filed with the SEC on October 2, 2014.
   
 (16)(12)Incorporated by reference to the Registrant’s Annual Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on June 30, 2015.
   
 (17)Incorporated by reference to the Registrant’s Annual Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on August 25, 2015.
(18)(13)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on December 15, 2015.
(19)Incorporated by reference to the Registrant’s Current Report on Form 8-K as an exhibit, numbered as indicated above, filed with the SEC on April 22, 2016.

 

 2120 

 

SIGNATURESSIGNATURES

 

In accordance with the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  MOJO ORGANICS, INC.
   
Dated: October 25, 2019August 14, 2020By:/s/ Glenn Simpson
  Glenn Simpson
  Chief Executive Officer and Chairman
  (Principal Executive and Principal Financial Officer)

 

 2221